Portage Biotech Inc.
PRTG
$5.33
-$0.20-3.62%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.87% | 93.35% | 36.79% | -663.34% | 12.86% |
| Total Depreciation and Amortization | -12.50% | -38.46% | -13.33% | 0.00% | 36.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.95% | -104.56% | -38.94% | 602,416.67% | -100.33% |
| Change in Net Operating Assets | -111.98% | 409.27% | -47.64% | -124.74% | 31.85% |
| Cash from Operations | 7.47% | 45.98% | 9.04% | 20.06% | -24.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.11% | 25.00% | -9.09% | -10.00% | -42.86% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | 10,576.00% | -92.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 94.74% |
| Cash from Financing | -25.00% | -100.00% | -100.08% | 13,558.97% | -93.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.32% | -441.21% | -116.51% | 144.58% | -49.39% |
